1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors
(
- Contribution to journal › Article
- 2021
-
Mark
Practical considerations for nonfactor-replacement therapies in the treatment of haemophilia with inhibitors
(
- Contribution to journal › Scientific review
-
Mark
Principles of Care for Acquired Hemophilia
(
- Contribution to journal › Article
- 2019
-
Mark
Inhibitors in haemophilia A and B : Management of bleeds, inhibitor eradication, and strategies for difficult-to-treat patients
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Haemophilia B : Where are we now and what does the future hold?
(
- Contribution to journal › Scientific review
-
Mark
Practical aspects of extended half-life products for the treatment of haemophilia
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Outcome measures for adult and pediatric hemophilia patients with inhibitors
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Joint disease, the hallmark of haemophilia: What issues and challenges remain despite the development of effective therapies?
(
- Contribution to journal › Scientific review